PATENT CLAIM ANALYSIS

Application Number: 15921306
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["514", "275000"]

Abstract:
This invention relates to solid oral pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2- yl)carbamate (COMPOUND A) and the use of these formulations for treating proliferative diseases, such as solid tumor diseases.

Claim (Index 14):
The solid oral pharmaceutical formulation of  claim 7 , formulated as a capsule or a tablet.

Metadata:
- Claim Count in Document: 33.0
- Percentile: 90.0
- Lexical Diversity: 1.45
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15179190', '15452239', '14359121', '15455477', '14058071']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7712206001849966
- 35 USC 102 Novelty (BERT): 0.49532641401637
- Combined Prediction Score: 0.743631181568134
- Mean Citation Score: 221.203208
- Max Citation Score: 258.0542
- Similarity Product: 214.20851497350927

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test